Front. Pharmacol.
Frontiers in Pharmacology
Front. Pharmacol.
1663-9812
Frontiers Media S.A.
1534991
10.3389/fphar.2024.1534991
Pharmacology
Erratum
Erratum: Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism
Frontiers Production Office
10.3389/fphar.2024.1534991
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
09
12
2024
2024
15
1534991
26
11
2024
26
11
2024
Copyright © 2024 Frontiers Production Office.
2024
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Erratum on Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism by Hu K, Xu Y, Fan J, Liu H, Di C, Xu F, Wu L, Ding K, Zhang T, Wang L, Ai H, Xie L, Wang G and Liang Y (2024). Front. Pharmacol. 15:1387409. doi: 10.3389/fphar.2024.1387409
glutathione
acute hepatic encephalopathy
oxidative stress
endoplasmic reticulum stress
iNOS/ATF4/Ddit3
section-at-acceptance
Neuropharmacology
Due to a production error, an incorrect number was provided for “the National Natural Science Foundation of China”. The correct number is 82274194.
The publisher apologizes for this mistake. The original version of this article has been updated.